Belgium, Mont Saint-Guibert, April 10 – Cellistic, a pioneer in induced pluripotent stem cells (iPSC)-based cell therapies, is launching the Echo™-NK platform to enable the scalable manufacturing of allogeneic cell therapies to target multiple diseases. Natural Killer (NK) cells are increasingly leveraged in these therapies for their ability to destroy harmful cancerous cells in their early stages, making them a promising option for the treatment of blood cancers, solid tumors, and autoimmune diseases. Cellistic’s Echo™-NK platform provides drug developers with a commercially viable solution for an Off-the-Shelf NK cell therapy. [Read more…]
Exploring Personal Stem Cell Banking within Regenerative Medicine: A Conversation with Kevin Ferber, COO of American Cell Technology
As the world of healthcare continues to evolve, regenerative medicine is emerging as a cornerstone of personalized, proactive health. In line with the mission of the 2025 HEALinc Global Summit – which aims to restore whole-person health through cutting-edge technologies, mentorship and education – the potential of stem cell therapy is poised to redefine our approach to health, longevity and wellness. Founded in 2018 by Dr. Desirée Cox (MD, MPhil, PhD), the HEALinc Global Summit brings together leaders and innovators to explore the latest scientific breakthroughs in healthy longevity and regenerative medicine. This year’s Summit will be held at the Atlantis Resort in The Bahamas from April 27th – 29th, 2025. [Read more…]
How Human iPSCs are Revolutionizing Drug Discovery in 2025
Drug discovery involves high cost and uncertain outcomes. Only a few companies can take the risk of investing enormous amounts of money into research and testing, only to see undesirable side effects emerge during the final human clinical trials. In many cases, companies are spending millions of dollars to fail during clinical testing.
Thankfully, some new medicines are now being tested for safety on specialized cells developed from human pluripotent cell lines. Cell types which are increasingly being used within drug discovery applications include heart (cardiomyocytes) and liver cells (hepatocytes), which are the organs where 80% of drug failures occur. [Read more…]
The Role of iPSCs in Farm Animals and Wildlife Conservation
Since their discovery in 2006, induced pluripotent stem cells (iPSCs) have been potently transforming regenerative medicine, biotechnology, and conservation. Their ability to be reprogrammed from adult somatic cells unlocks new possibilities for enhancing farm animal reproduction, boosting disease resistance, and improving food quality, while also playing a pivotal role in wildlife conservation and species revival. However, their use raises ethical concerns, including the risks of genetic modification, unforeseen ecological consequences, and the moral dilemmas surrounding species de-extinction. [Read more…]
Stem Cell Stocks: A Complete List from “A” to “Z”
Biotech investing has become increasingly attractive, with stem cell research standing out as a sector ripe with innovation and potential. Stem cell technology, with its ability to revolutionize treatments for illnesses, reverse injuries, and beyond, has drawn significant attention from investors looking to capitalize on groundbreaking advancements. But with so many companies entering the field, it can be challenging to track the leading players and emerging opportunities.
In this comprehensive guide, we provide a list of stem cell stocks, categorized from A to Z, to help you navigate this dynamic market. Whether you’re a seasoned investor seeking diversification or a biotech enthusiast eager to support transformative science, this article will highlight all known stem cell stocks that are listed on the public markets. [Read more…]
- « Previous Page
- 1
- …
- 36
- 37
- 38
- 39
- 40
- …
- 200
- Next Page »